Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted quinoxaline compounds as inhibitors of FGFR tyrosine kinases

Substituted quinoxaline compounds as inhibitors of FGFR tyrosine kinases

US Patent 12351571 · Granted Jul 8, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds for the treatment of BRAF-associated diseases and disorders2025
Compounds for the treatment of BRAF-associated diseases and disorders2025
Method for increasing number of proteins identified by mass spectrometry2025
5- and 6-azaindole compounds for inhibition of Bcr-Abl tyrosine kinases2025
FGFR3 inhibitor compounds2025
Protein tyrosine phosphatase inhibitors2025
Substituted pyrazolo[1,5-a]pyridine compounds as inhibitors of FGFR tyrosine kin2024
Substituted pyrazolo[1,5-a]pyridine compounds as inhibitors of FGFR tyrosine kin2024
Substituted pyrazolo[1,5-a]pyridine compounds as inhibitors of FGFR tyrosine kin2024
Substituted pyrazolo[1,5-a]pyridine compounds as inhibitors of FGFR tyrosine kin2024
Protective membrane for electrochemical cells2024
Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors2024